Global Scans · Nanotechnology · Weekly Summary

• Nanomedicine in 2026 and beyond will not sit on a single headline-grabbing breakthrough; it will be hiding in the boring bits. Azonano
• In 2026, nano R&D will be driven less by discovering entirely new nanomaterials and more by making complex nanomedicines efficient, robust and scalable. Azonano
• Global coordinated policies, with shared data, can help allay concerns associated with possible toxicity or environmental hazards to create safe development and deployment under nanomedicine. BioMed Central
• The work that really makes waves in 2026 will focus on data-rich, AI-supported nano processes with strong human oversight, enabling faster, safer and more predictable development of nanomedicines. Azonano
• If previously nanomedicine was about proving that lipid nanoparticles, polymer carriers, or smart nanoconstructs can deliver drugs, 2026 is about ensuring they do so safely, consistently, and under regulatory pressure. Azonano
• For the Dutch process analytical technology company InProcess-LSP, 2026 is the year nanomedicine steps out of the proof-of-concept phase and into the work of safe, reliable production. Azonano
• China's AI chip self-sufficiency rate will rise significantly by 2027, with some suggesting that China is only nanoseconds or a mere split second behind the US in AI, particularly in certain specialized domains. FinancialContent
• In the year 2026, the industry size of nanotechnology drug delivery is assessed at USD 116.66 billion. Research Nester
• Healthcare technology trends revolutionizing medicine in 2026 include artificial intelligence and machine learning, virtual, augmented, and mixed reality, telehealth solutions, and nanomedicine. MindInventory

Last updated: 28 December 2025